Suparshva Pharma Private Limited
About Suparshva Pharma Private Limited
Data last updated:
Suparshva Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2010PTC203832. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Bhaumik Rohit Shah and Nikesh Shailesh Parekh.
Its last annual general meeting (AGM) was held on 02 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹90,100. For the same year it recorded a net loss of ₹1.66 Lakh (net margin -184.6%) and EBITDA of -₹1.66 Lakh (EBITDA margin -184.6%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 28% over five years.
As per MCA filings, the company has open charges of ₹90 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Suparshva Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1st Floor Gala No. 6 Hitex Industrial Estate Behind Petrol Pump S.V. Road Dahisar E, Ast, Mumbai, Maharashtra, India – 400068
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Suparshva Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Suparshva Pharma Private Limited
FY 2025 filings availableSuparshva Pharma Private Limited reported revenue of ₹90,100 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 28% over five years. EBITDA fell 737% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -184.6% | ||||
| Net Profit Margin | -184.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suparshva Pharma Private Limited, buy the company report.
Board of directors of Suparshva Pharma Private Limited
Suparshva Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaumik Rohit Shah | Director | 08 Jun 2010 | 16 Years 4 Months | Current |
| Nikesh Shailesh Parekh Also directs: S. Parikh Pharma Private Limited, Hiniss Consumer Private Limited | Director | 08 Jan 2011 | 15 Years 9 Months | Current |
| Ashwin Mehta Shantilal Also directs: S. Parikh Pharma Private Limited | Director | 08 Jun 2010 | 16 Years 4 Months | Current |
| Ankit Hemant Shah Also directs: S. Parikh Pharma Private Limited | Director | 03 Dec 2010 | 15 Years 10 Months | Current |
Peer comparison
Suparshva Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Associated Auxichem Private Limited | ₹91,626 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Bravo Healthcare Limited | ₹91,496 (FY 2018) | -22.0% | Navi Mumbai, Maharashtra, India | |||
| Mccoy Performance Silicones Private Limited | ₹91,201 (FY 2025) | -73.0% | New Delhi, Delhi, India | |||
| Hopegen Pharma Private Limited | ₹90,720 (FY 2025) | Bhubaneswar, Odisha, India | ||||
| Navratna Minerals and Chemicals Private Limited | ₹90,666 (FY 2025) | 88.0% | Nagpur, Maharashtra, India | |||
| Suparshva Pharma Private Limitedthis company | ₹90,100 (FY 2025) | -₹1.66 Lakh | -184.6% | Mumbai, Maharashtra, India | ||
| Apex Remedies Private Limited | ₹90,000 (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Nandesari Fertiliser Industries Private Limited | ₹89,949 (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| The Rang Udhyog Private Limited | ₹89,533 (FY 2024) | 31.0% | Ahmedabad, Gujarat, India | |||
| Panerai Chemicals Private Limited | ₹89,375 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Linear Pharma Private Limited | ₹89,127 (FY 2025) | 6.0% | Delhi, India |
To see the full peer comparison of Suparshva Pharma Private Limited, buy the company report.
Auditor
Suparshva Pharma Private Limited is audited by Sandip V. Doshi & Co. for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sandip V. Doshi & Co. | FY 2015 |
Shareholding
The shareholding of Suparshva Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Suparshva Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Oct 2011 | 10318552 | Vasai Vikas Sahakari Bank Ltd | ₹90 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Suparshva Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suparshva Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Suparshva Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Suparshva Pharma Private Limited, buy the company report.
Recent activity
Suparshva Pharma Private Limited has 7 board changes on record since 2010: 4 appointments and 3 cessations. The latest: Ankit Hemant Shah ceased to be Additional Director on 05 Dec 2011.
Frequently asked questions
Suparshva Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2010 (16+ years old) and is registered under CIN U74999MH2010PTC203832.
Suparshva Pharma has 4 current directors:
- Bhaumik Rohit Shah - Director
- Nikesh Shailesh Parekh - Director
- Ashwin Mehta Shantilal - Director
- Ankit Hemant Shah - Director
The latest financial statements of Suparshva Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 02 September 2025. Year-wise statements from 2015 are in the company report.
No. Suparshva Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Suparshva Pharma is U74999MH2010PTC203832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suparshva Pharma was incorporated on 08 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Suparshva Pharma by revenue are Associated Auxichem Private Limited, Bravo Healthcare Limited, Mccoy Performance Silicones Private Limited, Hopegen Pharma Private Limited, Navratna Minerals and Chemicals Private Limited and 5 more, all in the Chemicals industry (Formulations, Industrial Chemicals).
Ankit Hemant Shah ceased to be Additional Director on 05 Dec 2011. Nikesh Shailesh Parekh ceased to be Additional Director on 05 Dec 2011. Nikesh Shailesh Parekh was appointed as Director on 08 Jan 2011. Suparshva Pharma has 7 board changes on record in total.
The registered office of Suparshva Pharma is at 1st Floor Gala No. 6 Hitex Industrial Estate Behind Petrol Pump S.V. Road Dahisar E, Ast, Mumbai, Maharashtra, India – 400068.
Suparshva Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Suparshva Pharma has open charges of ₹90 Lakh and no satisfied charges on record as per latest MCA filings.